FDA Warns Again About Robotic Mastectomy, Breaks New Ground FDA Warns Again About Robotic Mastectomy, Breaks New Ground
Use of robotic mastectomy for breast cancer is experimental and a ' significant ' risk, says the US Food and Drug Administration.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Hematology | Mastectomy